1. Home
  2. NWE vs ABCL Comparison

NWE vs ABCL Comparison

Compare NWE & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NorthWestern Energy Group Inc.

NWE

NorthWestern Energy Group Inc.

HOLD

Current Price

$71.78

Market Cap

4.2B

Sector

Utilities

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.44

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWE
ABCL
Founded
1923
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.5B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
NWE
ABCL
Price
$71.78
$11.44
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$66.50
$8.40
AVG Volume (30 Days)
317.7K
8.9M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
3.76%
N/A
EPS Growth
N/A
10.91
EPS
1.43
N/A
Revenue
$1,610,559,000.00
$75,128,000.00
Revenue This Year
$8.84
N/A
Revenue Next Year
$5.31
$21.85
P/E Ratio
$49.50
N/A
Revenue Growth
6.38
160.56
52 Week Low
$55.50
$2.75
52 Week High
$75.18
$12.58

Technical Indicators

Market Signals
Indicator
NWE
ABCL
Relative Strength Index (RSI) 55.90 61.25
Support Level $68.94 $10.44
Resistance Level $71.97 $12.58
Average True Range (ATR) 1.26 0.67
MACD 0.13 -0.19
Stochastic Oscillator 83.29 46.50

Price Performance

Historical Comparison
NWE
ABCL

About NWE NorthWestern Energy Group Inc.

NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric, which includes the generation, purchase, transmission, and distribution of electricity, and Natural Gas, which includes the production, purchase, transmission, storage, and distribution of natural gas. It uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: